Promotion of CHIP-Mediated p53 Degradation Protects the Heart From Ischemic Injury
- 11 June 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 106 (11) , 1692-1702
Abstract
Rationale : The number of patients with coronary heart disease, including myocardial infarction, is increasing and novel therapeutic strategy is awaited. Tumor suppressor protein p53 accumulates in the myocardium after myocardial infarction, causes apoptosis of cardiomyocytes, and plays an important role in the progression into heart failure. Objectives : We investigated the molecular mechanisms of p53 accumulation in the heart after myocardial infarction and tested whether anti-p53 approach would be effective against myocardial infarction. Methods and Results : Through expression screening, we found that CHIP (carboxyl terminus of Hsp70-interacting protein) is an endogenous p53 antagonist in the heart. CHIP suppressed p53 level by ubiquitinating and inducing proteasomal degradation. CHIP transcription was downregulated after hypoxic stress and restoration of CHIP protein level prevented p53 accumulation after hypoxic stress. CHIP overexpression in vivo prevented p53 accumulation and cardiomyocyte apoptosis after myocardial infarction. Promotion of CHIP function by heat shock protein (Hsp)90 inhibitor, 17-allylamino-17-demethoxy geldanamycin (17-AAG), also prevented p53 accumulation and cardiomyocyte apoptosis both in vitro and in vivo. CHIP-mediated p53 degradation was at least one of the cardioprotective effects of 17-AAG. Conclusions : We found that downregulation of CHIP level by hypoxia was responsible for p53 accumulation in the heart after myocardial infarction. Decreasing the amount of p53 prevented myocardial apoptosis and ameliorated ventricular remodeling after myocardial infarction. We conclude that anti-p53 approach would be effective to treat myocardial infarction.Keywords
This publication has 36 references indexed in Scilit:
- Heart Disease and Stroke Statistics—2007 UpdateCirculation, 2007
- Bax deficiency reduces infarct size and improves long-term function after myocardial infarctionCell Biochemistry and Biophysics, 2007
- Transgenic Expression of Bcl-2 Modulates Energy Metabolism, Prevents Cytosolic Acidification During Ischemia, and Reduces Ischemia/Reperfusion InjuryCirculation Research, 2004
- The ubiquitin ligase COP1 is a critical negative regulator of p53Nature, 2004
- Bax ablation protects against myocardial ischemia-reperfusion injury in transgenic miceAmerican Journal of Physiology-Heart and Circulatory Physiology, 2003
- A mechanistic role for cardiac myocyte apoptosis in heart failureJournal of Clinical Investigation, 2003
- Pirh2, a p53-Induced Ubiquitin-Protein Ligase, Promotes p53 DegradationCell, 2003
- Surfing the p53 networkNature, 2000
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997